We are live on ! Find out more
CBIO

Crescent Biopharma

58 hedge funds and large institutions have $72.5M invested in Crescent Biopharma in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more call options, than puts

Call options by funds: $1.06M | Put options by funds: $931K

0.11% less ownership

Funds ownership: 0.71%0.61% (-0.11%)

26% less funds holding

Funds holding: 7858 (-20)

32% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 22

34% less capital invested

Capital invested by funds: $110M → $72.5M (-$37.8M)

69% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 29

Holders
58
Holders Change
-20
Holders Change %
-25.64%
% of All Funds
1.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
15
Reduced
22
Closed
29
Calls
$1.06M
Puts
$931K
Net Calls
+$132K
Net Calls Change
+$364K